Comparison of HIV-1 Mother-to-Child Transmission After Single-Dose Nevirapine Prophylaxis Among African Women With Subtypes A, C, and D
- 1 August 2006
- journal article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 42 (4) , 518-521
- https://doi.org/10.1097/01.qai.0000221676.22069.b8
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Nevirapine (NVP) Resistance in Women with HIV‐1 Subtype C, Compared with Subtypes A and D, after the Administration of Single‐Dose NVPThe Journal of Infectious Diseases, 2005
- Preferential in-utero transmission of HIV-1 subtype C as compared to HIV-1 subtype A or DAIDS, 2004
- Nevirapine and Zidovudine at Birth to Reduce Perinatal Transmission of HIV in an African SettingJAMA, 2004
- Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trialThe Lancet, 2003
- Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trialThe Lancet, 2003
- Genetic diversity of HIV-1 in western KenyaAIDS, 2003
- Influence of human immunodeficiency virus type 1 subtype on mother-to-child transmissionJournal of General Virology, 2003
- Identification of Ugandan HIV Type 1 Variants with Unique Patterns of Recombination in pol Involving Subtypes A and DAIDS Research and Human Retroviruses, 2002
- Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)AIDS, 2001
- Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialThe Lancet, 1999